These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25609598)

  • 41. An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.
    Dwyer DB; Kalman JL; Budde M; Kambeitz J; Ruef A; Antonucci LA; Kambeitz-Ilankovic L; Hasan A; Kondofersky I; Anderson-Schmidt H; Gade K; Reich-Erkelenz D; Adorjan K; Senner F; Schaupp S; Andlauer TFM; Comes AL; Schulte EC; Klöhn-Saghatolislam F; Gryaznova A; Hake M; Bartholdi K; Flatau-Nagel L; Reitt M; Quast S; Stegmaier S; Meyers M; Emons B; Haußleiter IS; Juckel G; Nieratschker V; Dannlowski U; Yoshida T; Schmauß M; Zimmermann J; Reimer J; Wiltfang J; Reininghaus E; Anghelescu IG; Arolt V; Baune BT; Konrad C; Thiel A; Fallgatter AJ; Figge C; von Hagen M; Koller M; Lang FU; Wigand ME; Becker T; Jäger M; Dietrich DE; Scherk H; Spitzer C; Folkerts H; Witt SH; Degenhardt F; Forstner AJ; Rietschel M; Nöthen MM; Mueller N; Papiol S; Heilbronner U; Falkai P; Schulze TG; Koutsouleris N
    JAMA Psychiatry; 2020 May; 77(5):523-533. PubMed ID: 32049274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained Molecular Pathology Across Episodes and Remission in Major Depressive Disorder.
    Scifo E; Pabba M; Kapadia F; Ma T; Lewis DA; Tseng GC; Sibille E
    Biol Psychiatry; 2018 Jan; 83(1):81-89. PubMed ID: 28935211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology.
    Schubert KO; Föcking M; Cotter DR
    Schizophr Res; 2015 Sep; 167(1-3):64-72. PubMed ID: 25728835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dimensions underlying psychotic and manic symptomatology: Extending normal-range personality traits to schizophrenia and bipolar spectra.
    Wilson S; Sponheim SR
    Compr Psychiatry; 2014 Nov; 55(8):1809-19. PubMed ID: 25091283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Affective lability across psychosis spectrum disorders.
    Høegh MC; Melle I; Aminoff SR; Laskemoen JF; Büchmann CB; Ueland T; Lagerberg TV
    Eur Psychiatry; 2020 May; 63(1):e53. PubMed ID: 32372737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventral anterior cingulate connectivity distinguished nonpsychotic bipolar illness from psychotic bipolar disorder and schizophrenia.
    Anticevic A; Savic A; Repovs G; Yang G; McKay DR; Sprooten E; Knowles EE; Krystal JH; Pearlson GD; Glahn DC
    Schizophr Bull; 2015 Jan; 41(1):133-43. PubMed ID: 24782562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
    Misra M; Papakostas GI; Klibanski A
    J Clin Psychiatry; 2004 Dec; 65(12):1607-18; quiz 1590, 1760-1. PubMed ID: 15641865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
    Hill SK; Reilly JL; Keefe RS; Gold JM; Bishop JR; Gershon ES; Tamminga CA; Pearlson GD; Keshavan MS; Sweeney JA
    Am J Psychiatry; 2013 Nov; 170(11):1275-84. PubMed ID: 23771174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses.
    Tandon N; Nanda P; Padmanabhan JL; Mathew IT; Eack SM; Narayanan B; Meda SA; Bergen SE; Ruaño G; Windemuth A; Kocherla M; Petryshen TL; Clementz B; Sweeney J; Tamminga C; Pearlson G; Keshavan MS
    Schizophr Res; 2017 Apr; 182():74-83. PubMed ID: 27789186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. System-based proteomic and metabonomic analysis of the Df(16)A
    Wesseling H; Xu B; Want EJ; Holmes E; Guest PC; Karayiorgou M; Gogos JA; Bahn S
    Mol Psychiatry; 2017 Mar; 22(3):384-395. PubMed ID: 27001617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis.
    Huang JT; Leweke FM; Oxley D; Wang L; Harris N; Koethe D; Gerth CW; Nolden BM; Gross S; Schreiber D; Reed B; Bahn S
    PLoS Med; 2006 Nov; 3(11):e428. PubMed ID: 17090210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes.
    Mansur RB; Fries GR; Subramaniapillai M; Frangou S; De Felice FG; Rasgon N; McEwen B; Brietzke E; McIntyre RS
    J Psychiatr Res; 2018 Dec; 107():128-135. PubMed ID: 30391805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder.
    Hughes HK; Yang H; Lesh TA; Carter CS; Ashwood P
    J Neuroinflammation; 2022 Dec; 19(1):287. PubMed ID: 36463221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.
    Wesseling H; Guest PC; Lee CM; Wong EH; Rahmoune H; Bahn S
    Mol Autism; 2014; 5():38. PubMed ID: 25061506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutamatergic hypofunction in medication-free major depression: Secondary effects of affective diagnosis and relationship to peripheral glutaminase.
    Wise T; Taylor MJ; Herane-Vives A; Gammazza AM; Cappello F; Lythgoe DJ; Williams SC; Young AH; Cleare AJ; Arnone D
    J Affect Disord; 2018 Jul; 234():214-219. PubMed ID: 29544167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population.
    Chang WC; Wong CSM; Chen EYH; Lam LCW; Chan WC; Ng RMK; Hung SF; Cheung EFC; Sham PC; Chiu HFK; Lam M; Lee EHM; Chiang TP; Chan LK; Lau GKW; Lee ATC; Leung GTY; Leung JSY; Lau JTF; van Os J; Lewis G; Bebbington P
    Schizophr Bull; 2017 Oct; 43(6):1280-1290. PubMed ID: 28586480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homer1a protein expression in schizophrenia, bipolar disorder, and major depression.
    Leber SL; Llenos IC; Miller CL; Dulay JR; Haybaeck J; Weis S
    J Neural Transm (Vienna); 2017 Oct; 124(10):1261-1273. PubMed ID: 28815330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
    Kimoto S; Zaki MM; Bazmi HH; Lewis DA
    JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.